First Trust Direct Indexing’s AstraZeneca AZN Stock Holding History

First Trust Direct Indexing’s Portfolio AZN Stock Details AZN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q4	–	Sell	-16,530	Closed	-$2.58M	–	86
2024 Q3	$2.58M	Buy	16,530 +623	+4%	+$101K	0.14%	147
2024 Q2	$2.48M	Buy	15,907 +1,432	+10%	+$215K	0.15%	121
2024 Q1	$1.96M	Buy	14,475 +399	+3%	+$52.8K	0.15%	146
2023 Q4	$1.9M	Sell	14,076 -194	-1%	-$25.2K	0.17%	130
2023 Q3	$1.93M	Sell	14,270 -3,901	-21%	-$533K	0.22%	101
2023 Q2	$2.6M	Sell	18,171 -83	-0.5%	-$12.2K	0.29%	58
2023 Q1	$2.53M	Buy	18,254 +1,318	+8%	+$177K	0.3%	63
2022 Q4	$2.3M	Sell	16,936 -903	-5%	-$113K	0.3%	70
2022 Q3	$1.96M	Buy	17,839 +523	+3%	+$66.3K	0.29%	68
2022 Q2	$2.29M	Buy	17,316 +3,800	+28%	+$499K	0.32%	59
2022 Q1	$1.79M	Sell	13,516 -2,680	-17%	-$321K	0.22%	92
2021 Q4	$1.89M	Buy	16,196 +354	+2%	+$41.7K	0.24%	82
2021 Q3	$1.9M	Buy	15,842 +7,109	+81%	+$828K	0.27%	77
2021 Q2	$1.05M	Buy	8,733 +4,443	+104%	+$487K	0.16%	165
2021 Q1	$427K	Buy	4,290 +112	+3%	+$11.3K	0.11%	247
2020 Q4	$418K	Buy	+4,178	New	+$443K	0.11%	224

Other funds holding AZN

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return

Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Jennison Associates New York $145B AUM 34.61% 1-Year Est. Return

Sanders Capital West Palm Beach, Florida $83.9B AUM 37.89% 1-Year Est. Return

First Trust Direct Indexing's AZN Position: Q4 2024 in Review

First Trust Direct Indexing sold out of AstraZeneca (AZN) in Q4 2024, closing a stake of 16,530 shares — an estimated $2.58M sold.

First Trust Direct Indexing first reported a position in AZN in Q4 2020 and held it in 16 quarters. The position peaked at $2.6M in Q2 2023. 1,218 funds tracked by Wall St. Rank hold AZN as of Q4 2024.

First Trust Direct Indexing reported no remaining AstraZeneca position as of Q4 2024 after selling out during the quarter.
First Trust Direct Indexing sold 16,530 AstraZeneca shares in Q4 2024, an estimated $2.58M.
First Trust Direct Indexing first reported a position in AstraZeneca in Q4 2020 and held it in 16 quarters.
First Trust Direct Indexing's AstraZeneca position peaked at $2.6M in Q2 2023.
1,218 funds tracked by Wall St. Rank held AstraZeneca as of Q4 2024.

Based on First Trust Direct Indexing's 13F filing for Q4 2024.